AQST 8-K: SEC filing

Filed with the SEC on · accession 0001398733-26-000079

AQST filed a 8-K (current report) with the SEC on Nov 16, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Summary of the filing

Aquestive Therapeutics furnished an investor presentation given at the Jefferies Global Healthcare Conference on November 16, 2026, via a Regulation FD disclosure on Form 8-K.

Key details

RegistrantAquestive Therapeutics, Inc.
Host of the global healthcare conference where the presentation was givenJefferies
Chief financial officerA. Ernest Toth, Jr.

✦ Ask GOAX AI about this filing — what it means for AQST, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for AQST?

Click here

Frequently asked questions

What did AQST file with the SEC on Nov 16, 2026?

AQST filed a 8-K (SEC filing). Aquestive Therapeutics furnished an investor presentation given at the Jefferies Global Healthcare Conference on November 16, 2026, via a Regulation FD disclosure on Form 8-K.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other AQST SEC filings

Get alerts when AQST files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days